translumina gmbh

Translumina GmbH, Germany is a development and manufacturing specialist of medical devices being used in interventional cardiology and radiology. Our flagship products, YUKON® Choice PC and YUKON® Chrome PC, represent the 3rd generation metallic drug eluting stents. Uniquely, these DES products favorably make use of the synergy of combining drug - biodegradable polymer been coated on the abluminal microporous stent surface, thus creating optimum drug release kinetics (Sirolimus). Customers benefit from a wide range of stent sizes from Φ 2.0 mm to Φ 4.0 mm and lengths from 8 mm to 40 mm. YUKON® Choice PC passed very successfully randomized clinical trials with 10 years follow-up (2603 patients in ISAR test 4). YUKON® Choice PC, again and repeatedly has been referenced along with US FDA approved products in the European Society of Cardiology Guidelines, latest in the ESC guidelines for myocardial revascularization 2018 due to its strength of clinical data. YUKON® Choice PC has published data in index journals like Journal of American College of Cardiology, European Heart Journal, Biomaterials, Circulation and EuroIntervention. Our other products encompass a wide range of bare metal stents and coronary angioplasty balloons. Translumina GmbH – trust is what counts!

Medical Devices
Stuttgart, Baden-Württemberg
Founded in unknown
11-50 employees

Translumina GmbH, Germany is a development and manufacturing specialist of medical devices being used in interventional cardiology and radiology. Our flagship products, YUKON® Choice PC and YUKON® Chrome PC, represent the 3rd generation metallic drug eluting stents. Uniquely, these DES products favorably make use of the synergy of combining drug - biodegradable polymer been coated on the abluminal microporous stent surface, thus creating optimum drug release kinetics (Sirolimus). Customers benefit from a wide range of stent sizes from Φ 2.0 mm to Φ 4.0 mm and lengths from 8 mm to 40 mm. YUKON® Choice PC passed very successfully randomized clinical trials with 10 years follow-up (2603 patients in ISAR test 4). YUKON® Choice PC, again and repeatedly has been referenced along with US FDA approved products in the European Society of Cardiology Guidelines, latest in the ESC guidelines for myocardial revascularization 2018 due to its strength of clinical data. YUKON® Choice PC has published data in index journals like Journal of American College of Cardiology, European Heart Journal, Biomaterials, Circulation and EuroIntervention. Our other products encompass a wide range of bare metal stents and coronary angioplasty balloons. Translumina GmbH – trust is what counts!

Company Information

Industry
Medical Devices
Company Type
Privately Held
Founded
unknown
Employee Range
11-50
Revenue Range
Not available

Location

Address
Neue Rottenburger Str. 50 Hechingen Hechingen
City
Stuttgart
Region
Baden-Württemberg
Postal Code
72379
Country
Germany

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions